UC Irvine

The collaboration will give the company access to UCI research in diagnostic platforms, life science applications, devices, and data analytics.

The award will go toward the development of MicrobeDx's technology for detecting the presence of bacteria in clinical urine specimens and to which antibiotics they are susceptible.

Researchers at Tufts and their collaborators recently demonstrated that the approach, which uses multiphoton microscopy, can distinguish between normal and cancerous skin.